Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: The EURODIAB complications study

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 316-322

  Crook, Martin A ^a   Pickup, John C ^a   Lumb, Peter J ^a   Georgino, Francesco ^b   Webb, David J ^c   Fuller, John H ^c  

^a GUY S HOSPITAL   (United Kingdom)

^b Policlinico Universitario   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN A1C; SIALIC ACID; TRIACYLGLYCEROL;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EXERCISE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING;

EID: 0035140759     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.316     Document Type: Article

References (41)

1. A new enzymatic method for the determination of sialic acid and its application as a marker of acute phase reactants
2. Serum sialic acid concentration and cardiovascular mortality
3. Serum sialic acid and acute phase proteins in type 1 and 2 diabetes
4. NIDDM as a disease of the innate immune system: Association of acute phase reactants and interleukin- 6 with metabolic syndrome X
5. Is type II diabetes mellitus a disease of the innate immune system?
6. Serum, sialic acid, a risk factor for cardiovascular disease, is increased in insulin-dependent diabetic patients with microalbuminuria and clinical proteinuria
7. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy
8. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study
9. Cardiovascular disease and its risk factors in IDDM in Europe
10. Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study
11. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study
12. The determination of serum or plasma sialic acid
13. Simple immunoturbimetric method for determining urinary albumin at low concentrations using centrifugal analyser
14. 1c
15. Serum sialic acid as a predictor of coronary artery atherosclerosis regression
16. Increase of sialic acid concentration in the plasma of patients with coronary disease
17. Serum sialic acid concentration and coronary heart disease in NIDDM
18. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy
19. Serum sialic acid and the long-term complications of IDDM
20. Serum sialic acid in non-insulin-dependent diabetes mellitus and its relationship to blood pressure and retinopathy
21. Relation of serum sialic acid to lipid concentrations
22. Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Frederickson's IIB phenotype
23. Serum sialic acid concentration and smoking: A population based study
24. The relationship between plasma sialic acid and fibrinogen in NIDDM
25. Relation between sialic acid concentrations and the haemostatic system in the elderly
26. Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects greater than 75 years of age
27. Regulation of the acute phase response by cytokines
28. The acute phase response
29. Cytokine regulation of endothelial cell function
30. Cytokine regulation of endothelial cell function: From molecular level to the bedside
31. Role of cytokines in inducing hyperlipidemia
32. Microalbuminuria as predictor of outcome
33. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM
34. Serum sialic acid in health and disease
35. Uneven distribution of sialic acids on luminal side of aortic endothelium
36. Characterisation of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients
37. Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes
38. Higher serum sialic acid in women than men with NIDDM: Possible relevance to increased cardiovascular risk in NIDDM women
39. Serum sialic acid levels in healthy individuals
40. Diabetes mellitus and macrovascular complications: An epidemiological perspective
41. The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient?